Screener
Upstream Bio, Inc. UPB Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net loss | $(80,293) | $(67,236) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 99 | 85 |
| Stock-based compensation expense | 9,001 | 5,232 |
| Net amortization of premiums and accretion of discounts on short-term investments | (793) | (2,720) |
| Non-cash lease expense | 307 | 272 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (104) | (324) |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s stock-based comp?
- Upstream Bio, Inc. (UPB) reported stock-based comp of $4.35M in Q2 2026.
- How has Upstream Bio, Inc.'s stock-based comp changed year-over-year?
- Upstream Bio, Inc.'s stock-based comp increased by 67.7% year-over-year, from $2.6M to $4.35M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Upstream Bio, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude